Endometrial stromal sarcoma: Treatment and patterns of recurrence

International Journal of Gynecological Cancer

Volumn 19, Issue 2, 2009, Pages 253-256

  Thomas, M Bijoy ^a   Keeney, Gary L ^b   Podratz, Karl C ^a   Dowdy, Sean C ^a,c  

^a Division of Gynecologic Surgery   (United States)

^b MAYO CLINIC   (United States)

^c NONE   (United States)

Author keywords

Endometrial stromal sarcoma; Lymphadenectomy; Surgical management

Indexed keywords

AROMATASE INHIBITOR; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE; PROGESTERONE; TAMOXIFEN; VINCRISTINE;

ABDOMINAL DISEASE; ADJUVANT THERAPY; ADULT; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM SARCOMA; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; LAPAROTOMY; LYMPHADENECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARAAORTIC LYMPHADENECTOMY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOSIS; ENDOMETRIUM TUMOR; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; SURVIVAL; TUMOR RECURRENCE;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SARCOMA, ENDOMETRIAL STROMAL; SURVIVAL ANALYSIS;

EID: 65649100480     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181999c5f     Document Type: Article

References (26)

1. Koss LG, Spiro RH, Brunschwig A. Endometrial stromal sarcoma. Surg Gynecol Obstet. 1965;121:531-537.
2. Norris HJ, Taylor HB. Mesenchymal tumors of uterus. A clinical and pathologic study of 53 endometrial stromal tumors. Cancer. 1966;19: 755-766.
3. Li N, Wu LY, Zhang HT, et al. Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases. Gynecol Oncol. 2008;108:306-311.
4. Geller MA, Argenta P, Bradley W, et al. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol. 2004;95:632-636.
5. Nordal RR, Kristensen GB, Kaern J, et al. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma. Gynecol Oncol. 1996;62: 254-259.
6. Gadducci A, Sartori E, Landoni F, et al. Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol. 1996;63: 247-253.
7. Chang KL, Crabtree GS, Lim-Tan SK, et al. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol. 1990;14:415-438.
8. Goff BA, Rice LW, Flelschhacker D, et al. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol. 1993;50:105-109.
9. Riopel J, Plante M, Renaud MC, et al. Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecol Oncol. 2005;96: 402-406.
10. Amant F, Vergote I, Moerman P. The classification of a uterine sarcoma as "high-grade endometrial stromal sarcoma" should be abandoned. Gynecol Oncol. 2004;95:412-413.
11. Leath CA, Huh WK, Hyde J, et al. A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol. 2007;105: 630-634.
12. Bodner K, Bodner-Adler B, Obermair A, et al. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol. 2001;81:160-165.
13. Ayhan A, Tuncer ZS, Tanir M, et al. Uterine sarcoma: the Hacettepe hospital experience of 88 consecutive patients. Eur J Gynecol Oncol. 1997;18:146-148.
14. Berchuck A, Rubin SC, Hoskins WJ, et al. Treatment of endometrial stromal tumors. Gynecol Oncol. 1990;36:60-65.
15. Sutton G, Blessing JA, Park R, et al. Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. Obstet Gynecol. 1996;87:747-750.
16. Kanjeekal S, Chambers A, Fung Kee Fung M, et al. Systemic therapy for advanced uterine sarcoma: a systematic review of the literature. Gynecol Oncol. 2005;97:624-637.
17. Paillocher N, Lortholary A, Abadie-Lacourtoisie S, et al. Low-grade endometrial stromal sarcoma: contribution of hormone therapy and etoposide. J Gynecol Obstet Biol Reprod (Paris). 2005;34:41-46.
18. Popiolek D, Yee H, Levine P, et al. MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus. Gynecol Oncol. 2003;90:353-357.
19. Leunen M, Breugelmans M, De Sutter P, et al. Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol Oncol. 2004;95:769-771.
20. Maluf FC, Sabbatini P, Schwartz L, et al. Endometrial stromal sarcoma: objective response to letrozole. Gynecol Oncol. 2001;82:384-388.
21. Chu MC, Mor G, Lim C, et al. Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol. 2003;90:170-176.
22. Scribner DR, Walker JL. Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace. Gynecol Oncol. 1998;71:458-460.
23. Yokoyama Y, Ono Y, Sakamoto T, et al. Asymptomatic intracardiac metastasis from a low-grade endometrial stromal sarcoma with successful surgical resection. Gynecol Oncol. 2004;92:999-1001.
24. Tabata T, Takeshima N, Hirai Y, et al. Low-grade endometrial stromal sarcoma with cardiovascular involvement-a report of three cases. Gynecol Oncol. 1999;75:495-498.
25. Whitlatch SP, Meyer RL. Recurrent endometrial stromal sarcoma resembling intravenous leiomyomatosis. Gynecol Oncol. 1987;28: 121-128.
26. Styron SL, Burke TW, Linville WK. Low-grade endometrial stromal sarcoma recurring over three decades. Gynecol Oncol. 1989;35:275-278.